FIRM FIXED PRICE
ADVANCED ACCELERATOR APPLICATIONS USA INC - VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
PIID: 36C24925N0259
Signed Date: Feb 10, 2026Effective Date: Dec 20, 2024End Date: Closed on Dec 19, 2025
Key Details
Description
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Contractor Information
Contractor: ADVANCED ACCELERATOR APPLICATIONS USA INC
UEI: JNM4NBNHFE66
CAGE Code: 3PTH3
Location: NEW YORK, NY
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.